102 related articles for article (PubMed ID: 2596350)
1. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
Karege F; Bovier P; Gaillard JM; Tissot R
Acta Psychiatr Scand; 1989 Nov; 80(5):499-504. PubMed ID: 2596350
[TBL] [Abstract][Full Text] [Related]
2. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
Halbreich U; Sharpless N; Asnis GM; Endicott J; Goldstein S; Vital-Herne J; Eisenberg J; Zander K; Kang BJ; Shindledecker R
Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
[TBL] [Abstract][Full Text] [Related]
4. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
Roy A; Jimerson DC; Pickar D
Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
[TBL] [Abstract][Full Text] [Related]
5. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
[TBL] [Abstract][Full Text] [Related]
6. Disruption of circadian MHPG rhythmicity in major depression.
Piletz JE; DeMet E; Gwirtsman HE; Halaris A
Biol Psychiatry; 1994 Jun; 35(11):830-42. PubMed ID: 8054405
[TBL] [Abstract][Full Text] [Related]
7. Apparent phase advance in diurnal MHPG rhythm in depression.
Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M
Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
[TBL] [Abstract][Full Text] [Related]
8. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review.
Yoshimura R; Nakamura J; Shinkai K; Ueda N
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):611-6. PubMed ID: 15276685
[TBL] [Abstract][Full Text] [Related]
9. Plasma MHPG and age at onset in depressed patients.
Karege F; Bovier P; Gaillard JM; Tissot R
Psychiatry Res; 1989 Oct; 30(1):103-5. PubMed ID: 2594867
[No Abstract] [Full Text] [Related]
10. Plasma MHPG in rapid cyclers and healthy twins.
Jimerson DC; Nurnberger JI; Post RM; Gershon ES; Kopin IJ
Arch Gen Psychiatry; 1981 Nov; 38(11):1287-90. PubMed ID: 7197905
[TBL] [Abstract][Full Text] [Related]
11. Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables.
Azorin JM; Pupeschi G; Valli M; Joanny P; Raucoules D; Lancon C; Tissot R
Acta Psychiatr Scand; 1990 Jan; 81(1):14-8. PubMed ID: 2330823
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic function and the dexamethasone suppression test in depression.
Morinobu S; Satoh H; Endoh M; Totsuka S
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
[TBL] [Abstract][Full Text] [Related]
13. Plasma MHPG in depression: effects of acute and chronic desipramine treatment.
Charney DS; Heninger GR; Sternberg DE; Roth RH
Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615
[TBL] [Abstract][Full Text] [Related]
14. Effects of desipramine on diurnal rhythms of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in depressed patients.
DeMet EM; Halaris AE; Gwirtsman HE; Reno RM; Becker PI
Psychopharmacol Bull; 1982 Oct; 18(4):221-3. PubMed ID: 6891473
[No Abstract] [Full Text] [Related]
15. Platelet membrane alpha 2-adrenergic receptors in depression.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
[TBL] [Abstract][Full Text] [Related]
16. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
Sacchetti E; Allaria E; Negri F; Biondi PA; Smeraldi E; Cazzullo CL
Biol Psychiatry; 1979 Jun; 14(3):473-84. PubMed ID: 476232
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of anxiety on total plasma MHPG in depressed patients.
Karege F; Bovier P; Hilleret H; Gaillard JM
J Affect Disord; 1993 Jul; 28(3):211-7. PubMed ID: 8408983
[TBL] [Abstract][Full Text] [Related]
18. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings.
Muscettola G; Potter WZ; Pickar D; Goodwin FK
Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853
[TBL] [Abstract][Full Text] [Related]
19. CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
Sharma RP; Javaid JI; Faull K; Davis JM; Janicak PG
Psychiatry Res; 1994 Jan; 51(1):51-60. PubMed ID: 7910975
[TBL] [Abstract][Full Text] [Related]
20. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
